{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T12:16:25Z","timestamp":1721477785649},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/bf02760699","type":"journal-article","created":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T11:07:20Z","timestamp":1200913640000},"page":"139-144","source":"Crossref","is-referenced-by-count":16,"title":["Growth hormone therapy"],"prefix":"10.1007","volume":"72","author":[{"given":"Anurag","family":"Bajpai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. S. N.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02760699_CR1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-55-5-1003","volume":"55","author":"L Russo","year":"1982","unstructured":"Russo L, Moore WV. A comparison of subcutaneous and intramuscular administration of human growth hormone in therapy of human growth hormone deficiency.J Clin Endocrinol Metab 1982; 55: 1003\u20131006.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1542\/peds.76.3.361","volume":"76","author":"DM Wilson","year":"1985","unstructured":"Wilson DM, Baker B, Hintz RL, Rosenfield RG. Subcutaneous verus intramuscular growth hormone therapy: growth and acute somatostatin response.Pediatrics 1985; 76: 361\u2013364.","journal-title":"Pediatrics"},{"key":"BF02760699_CR3","first-page":"1806","volume":"81","author":"MH MacGillivary","year":"1996","unstructured":"MacGillivary MH, Bapista J, Johanson A. Outcome of a four-year randomized study of daily versus three times weekly somatotropin treatment in prepubertal na\u00efve growth hormone deficient children.J Clin Endocrinol Metab 1996; 81: 1806\u20131809.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2265.1997.1610972.x","volume":"46","author":"A Teunenbroek Van","year":"1997","unstructured":"Van Teunenbroek A, de Munick Keizer-Schrama S, Stijnen Tet al. Growth response and levels of growth after two years growth hormone treatment are similar for once or twice daily regimen in girls with Turner syndrome.Clin Endocrinol (Oxford) 1997; 46: 451\u2013459.","journal-title":"Clin Endocrinol (Oxford)"},{"key":"BF02760699_CR5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000182733","volume":"39","author":"Z Zadik","year":"1993","unstructured":"Zadik Z, Liberman E, Altman Y, Chen M, Limoni Y, Landau H. Effect of timing of growth hormone on plasma growth-hormone-binding activity, insulin like growth factor-1 and growth in children with subnormal secretion of growth hormone.Horm Res 1993; 39: 188\u2013191.","journal-title":"Horm Res"},{"issue":"Suppl 2","key":"BF02760699_CR6","first-page":"715","volume":"15","author":"BJ Silverman","year":"2002","unstructured":"Silverman BJ, Blethen SL, Reiter EO, Attie KM, Neuwirth RB, Ford KM. A long-acting human growth hormone (Nutropin Depot): efficacy and safety following two years of treatment in children with growth hormone deficiency.J Pediatr Endocrinol Metab 2002; 15 (Suppl 2): 715\u2013722.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"BF02760699_CR7","first-page":"483","volume":"16","author":"JM Wit","year":"2002","unstructured":"Wit JM. Growth hormone therapy.Clinical Endocrinol Metab 2002; 16: 483\u2013504.","journal-title":"Clinical Endocrinol Metab"},{"key":"BF02760699_CR8","first-page":"336","volume":"74","author":"PM Martha","year":"1992","unstructured":"Martha PM, Gorman KM, Blizzard RM, Rogol AD, Veldhuis JD. Endogenous growth hormone secretion and clearance rates in normal boys, as determined by deconvolution analysis: relationship to age, pubertal status and body mass.J Clin Endocrinol Metab 1992; 74: 336\u2013344.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR9","first-page":"124","volume-title":"Clinical Pediatric Endocrinology","author":"RL Hintz","year":"2001","unstructured":"Hintz RL. Management of disorders of size. In Brook CGD, Hindmarsh PC, eds.Clinical Pediatric Endocrinology, 4th edn. London: Blackwell Science 2001; 124\u2013139.","edition":"4th edn"},{"key":"BF02760699_CR10","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jcem.84.4.5634","volume":"84","author":"MB Ranke","year":"1999","unstructured":"Ranke MB, Lindberg A, Chatelain P, Wilton P, Cutfield W, Albertson-Wikland K, Price DA. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with GH deficiency.J Clin Endocrinol Metab 1999; 84: 1174\u20131183.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1515\/JPEM.2000.13.S1.739","volume":"13","author":"V Muller","year":"2000","unstructured":"Muller V, Hoepffiner W, Kiess W, Keller E. Predictions of height velocity of prepubertal children with growth hormone deficiency in the first year of treatment with recombinant human growth hormone.J Pediatric Endocrinol Metab 2000; 13: 893\u2013897.","journal-title":"J Pediatric Endocrinol Metab"},{"key":"BF02760699_CR12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1530\/eje.0.1480515","volume":"148","author":"G Radetti","year":"2003","unstructured":"Radetti G, Buzi F, Paganini C, Pilotta A, Felappi B. Treatment of GH-deficient children with two different GH doses: effect on final height and cost-benefit implications.Eur J Endocrinol 2003; 148: 515\u2013518.","journal-title":"Eur J Endocrinol"},{"key":"BF02760699_CR13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/jcem.82.2.3734","volume":"82","author":"SL Blethen","year":"1997","unstructured":"Blethen SL, Bapista J, Kuntze J, Foley T, LaFranchi S, Johanson A. Adult height in growth hormone deficient children treated with biosynthetic GH: the Genetech growth study group.J Clin Endocrinol Metab 1997; 82: 418\u2013420.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1096-6374(02)00045-X","volume":"12","author":"T Tanaka","year":"2002","unstructured":"Tanaka T, Cohen P, Clayton PE, Laron Z, Hintz TL, Sizoneneko PC. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 2: Growth hormone treatment in growth hormone deficient children.Growth Horm IGF Res 2002; 12: 323\u2013341.","journal-title":"Growth Horm IGF Res"},{"key":"BF02760699_CR15","first-page":"211","volume-title":"Pediatric Endocrinology","author":"GR Rosenfield","year":"2002","unstructured":"Rosenfield GR, Cohen P. Disorders of growth hormone\/ insulin like growth factor and action. In Sperling MA, ed.Pediatric Endocrinology, 2nd edn. Philadelphia: WB Saunders, 2002; 211\u2013288.","edition":"2nd edn"},{"key":"BF02760699_CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1054\/ghir.2000.0175","volume":"10","author":"PE Clayton","year":"2000","unstructured":"Clayton PE, Cowell CT. Safety issues in children and adolescents during growth hormone therapy-a review.Growth Horm IGF Res 2000; 10: 306\u2013317.","journal-title":"Growth Horm IGF Res"},{"key":"BF02760699_CR17","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4471-1721-6","volume-title":"A longitudinal study of adolescent growth","author":"JM Buckler","year":"1990","unstructured":"Buckler JM: A longitudinal study of adolescent growth. London: Springer 1990."},{"key":"BF02760699_CR18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1651-2227.1996.tb14298.x","volume":"417","author":"T Tanaka","year":"1996","unstructured":"Tanaka T, Konatsu K, Takada G, Miyashita M, Ohno T. Prediction of adult height in healthy Japanese children.Acta Pediatr 1996; 417 (suppl): 57\u201360.","journal-title":"Acta Pediatr"},{"key":"BF02760699_CR19","first-page":"47","volume":"372","author":"R Stanhope","year":"1998","unstructured":"Stanhope R, Uruena M, Hindmarsh P, Leiper AD, Brook CG. Management of growth hormone deficiency through puberty.Acta Pediatr Scand 1998; 372 (suppl): 47\u201352.","journal-title":"Acta Pediatr Scand"},{"key":"BF02760699_CR20","first-page":"80","volume":"428","author":"K Albertson-Wikland","year":"1998","unstructured":"Albertson-Wikland K, Alm F, Aronsson Set al. Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results form an ongoing trial with different dose regimens.Acta Pediatr 1998; 428 (suppl): 80\u201384.","journal-title":"Acta Pediatr"},{"key":"BF02760699_CR21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1651-2227.1999.tb14359.x","volume":"88","author":"T Tanaka","year":"1999","unstructured":"Tanaka T, Satoh M, Yasunaga T, Horikawa R, Tanae A, Katsumata N, Tachibana K, Nose O, Hibi I. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.Acta Pediatr 1999; Suppl 88: 85\u201388.","journal-title":"Acta Pediatr"},{"key":"BF02760699_CR22","first-page":"569","volume":"85","author":"MV Merciq","year":"2000","unstructured":"Merciq MV, Eggers M, Avila A, Cutler GB Jr, Cassorola F. Near final height in pubertal growth hormone (GH) deficient parents treated with GH alone or in combination with leutenizing releasing hormone analog: results of a prospective, randomized trial.J Clin Endocrinol Metab 2000; 85: 569\u2013573.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR23","doi-asserted-by":"crossref","unstructured":"Cutfield WS, Lindberg A, Chatelain Pet al. Final height following growth hormone treatment idiopathic growth hormone deficiency in KIGS. In Ranke MB, Wilton P, eds.Growth Hormone Therapy in KIGS-10 Year Experience. Heidelberg 1999. Pp 93\u2013109.","DOI":"10.1111\/j.1651-2227.1999.tb14356.x"},{"key":"BF02760699_CR24","first-page":"80","volume":"49","author":"GP August","year":"1998","unstructured":"August GP, Julius JR, Blethen SL. Adult height in growth hormone deficient children treated with biosynthetic GH. The national cooperative growth study experience.Pediatrics 1998; 49: 80\u201385.","journal-title":"Pediatrics"},{"key":"BF02760699_CR25","doi-asserted-by":"crossref","unstructured":"Cacciari E, Cicognani A, Pirazolli Pet al. Final height of patients treated for isolated GH deficiency examination on 83 patients.Eur J Endocrinol 197; 137: 53\u201360.","DOI":"10.1530\/eje.0.1370053"},{"key":"BF02760699_CR26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000185487","volume":"48","author":"MB Ranke","year":"1997","unstructured":"Ranke MB, Price DA, Albertsson-Wikland K, Maes M, Lindbe A. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency.Horm Res 1997; 48: 62\u201371.","journal-title":"Horm Res"},{"key":"BF02760699_CR27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00441309","volume":"137","author":"EC Burns","year":"1981","unstructured":"Burns EC, Tanner JM, Preece MA, Cameron N. Final height and pubertal development in 55 children with idiopathic growth hormone deficiency.Eur J Pediatr 1981; 137: 155\u2013164.","journal-title":"Eur J Pediatr"},{"key":"BF02760699_CR28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/acta.0.1200409","volume":"120","author":"I Hibi","year":"1989","unstructured":"Hibi I, Tanaka T. Final height of patients with idiopathic growth hormone deficiency after long-term growth hormone treatment. Committee for Treatment of Growth Hormone Deficient Children, Growth Science Foundation, Japan.Acta Endocrinol (Copenh) 1989; 120: 409\u2013415.","journal-title":"Acta Endocrinol (Copenh)"},{"key":"BF02760699_CR29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000185487","volume":"48","author":"MB Rikken","year":"1997","unstructured":"Rikken MB, Massa GG, Wit JM. Final height in a large cohort of Dutch patients with growth hormone deficiency treated with growth hormone.Horm Res 1997; 48: 62\u201371.","journal-title":"Horm Res"},{"issue":"Suppl 12","key":"BF02760699_CR30","first-page":"37","volume":"8","author":"T Tanaka","year":"1999","unstructured":"Tanaka T, Takano K, Igarashi Yet al. Growth hormone (GH) treatment and puberty in GH treated GH children.Clin Pediatr Endocrinol 1999; 8 (Suppl 12): 37\u201344.","journal-title":"Clin Pediatr Endocrinol"},{"key":"BF02760699_CR31","first-page":"83","volume":"50","author":"M Lampit","year":"1998","unstructured":"Lampit M, Nave T, Hochberg Z. Water and sodium retention during short-term administration of growth hormone to short normal children.Horm Res 1998; 50: 83\u201388.","journal-title":"Horm Res"},{"key":"BF02760699_CR32","first-page":"822","volume":"80","author":"S Watanabe","year":"1989","unstructured":"Watanabe S, Tsunematsu Y, Fujimoto J, Korniyama A. Leukemia in patients treated with growth hormone.Lancet 1989; 80: 822\u2013825.","journal-title":"Lancet"},{"key":"BF02760699_CR33","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/S0022-3476(97)70008-8","volume":"131","author":"DB Allen","year":"1997","unstructured":"Allen DB, Rundle AC, Graves DA, Blethen SL. Risk of leukemia in children with growth hormone: review and reanalysis.J Pediatr 1997; 131: S32-S36.","journal-title":"J Pediatr"},{"key":"BF02760699_CR34","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/jcem.84.6.5716","volume":"84","author":"Y Nishi","year":"1999","unstructured":"Nishi Y, Tanaka T, Takano Ket al. Recent status in the occurrence of leukemia in growth hormone treated patients in Japan.J Clin Endocrinol Metab 1999; 84: 1961\u20131965.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR35","first-page":"4444","volume":"85","author":"AJ Swerdkow","year":"2000","unstructured":"Swerdkow AJ, Reddubgius RE, Higgins CDet al. Growth hormone treatment of children with brain tumors and risk of recurrence.J Clin Endocrinol Metab 2000; 85: 4444\u20134449.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR36","first-page":"1704","volume":"81","author":"SL Blethen","year":"1996","unstructured":"Blethen SL, Allen DB, Graves D, August G, Moshang T, Rosenfield R. Safety of recombinant deoxyribonucleic acid derived growth hormone: the national cooperative growth study experience.J Clin Endocrinol Metab 1996; 81: 1704\u20131710.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR37","first-page":"396","volume":"139","author":"EB Rappaport","year":"1985","unstructured":"Rappaport EB, Fife D. Slipped capital femoral epiphysis in growth hormone deficient patients.Am J Dis Child 1985; 139: 396\u2013399.","journal-title":"Am J Dis Child"},{"key":"BF02760699_CR38","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000185006","volume":"46","author":"SL Blethen","year":"1996","unstructured":"Blethen SL, Rundle AC. Slipped capital femoral ephiphysis in children treated with growth hormone.Horm Res 1996; 46: 113\u2013116.","journal-title":"Horm Res"},{"key":"BF02760699_CR39","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1210\/jcem.85.5.6598","volume":"85","author":"N Vahl","year":"2000","unstructured":"Vahl N, Juul A, Jorgenesen JOet al. Continuation of growth hormone (GH) treatment I GH deficient patients during transition form childhood to adulthood: a two year placebo-controlled study.J Clinical Endocrinol Metab 2000; 85: 1874\u20131881.","journal-title":"J Clinical Endocrinol Metab"},{"key":"BF02760699_CR40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000023298","volume":"50","author":"G Saggese","year":"1998","unstructured":"Saggese G, Ranke MB, Saenger Pet al. Diagnosis and treatment of growth hormone deficiency in children and adolescents: towards a consensus. Ten years after availability of recombinant growth hormone.Horm Res 1998; 50: 320\u2013340.","journal-title":"Horm Res"},{"key":"BF02760699_CR41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0022-3476(98)70452-4","volume":"132","author":"R Rosenfield","year":"1998","unstructured":"Rosenfield R, Attie K, Frane Jet al. Growth hormone therapy of Turner syndrome: beneficial effect on adult final height.J Pediatr 1998; 132: 319\u2013324.","journal-title":"J Pediatr"},{"key":"BF02760699_CR42","first-page":"1462","volume":"83","author":"J Carel","year":"1998","unstructured":"Carel J, Mathivon L, Gendrel Cet al. Near normalization of final height with adapted doses of growth hormone in Turner syndrome.J Clin Endocrinol Metab 1998; 83: 1462\u20131466.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR43","first-page":"635","volume":"81","author":"K Nillson","year":"1996","unstructured":"Nillson K, Albertson-Wikland K, Alm Jet al. Improved final height in girls with Turner syndrome treated with growth hormone and oxandrolone.J Clin Endocrinol Metab 1996; 81: 635\u2013640.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR44","first-page":"4607","volume":"84","author":"T Sas","year":"1999","unstructured":"Sas T, de Munic Keizer-Schrama S, Stijen Tet al. Near-normalization of heights in girls with Turner syndrome after long term growth hormone treatment: results of a randomized dose trial.J Clin Endocrinol Metab 1999; 84: 4607\u20134612","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR45","first-page":"3061","volume":"86","author":"P Saenger","year":"2001","unstructured":"Saenger P, Albertson-Wikland K, Cowy Get al. Recommendations of diagnosis and management of Turner syndrome.J Clin Endocrinol Metab 2001; 86: 3061\u20133069.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR46","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s004670000340","volume":"14","author":"A Hokken-Kolega","year":"2000","unstructured":"Hokken-Kolega A, Mulder P, De Jong Get al. Long term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency.Pediatr Nephrol 2000; 14: 701\u2013706.","journal-title":"Pediatr Nephrol"},{"issue":"343","key":"BF02760699_CR47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJM200009283431304","volume":"28","author":"D Haffner","year":"2000","unstructured":"Haffner D, Schaefer F, Nissel R, Wuhl E, Tonshoff B, Mehls O. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure.N Engl J Med 2000 28; 343: 923\u2013930.","journal-title":"N Engl J Med"},{"key":"BF02760699_CR48","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1210\/jcem.83.4.4703","volume":"83","author":"JG Buchlis","year":"1998","unstructured":"Buchlis JG, Irizarry L, Crotzer BCet al. Comparison of final height of growth hormone treated versus untreated children with idiopathic growth failure.J Clin Endocrinol Metab 1998; 83: 1075\u20131079.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR49","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1210\/jc.2002-021172","volume":"88","author":"Y Pareren Van","year":"2003","unstructured":"Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.J Clin Endocrinol Metab 2003; 88: 3584\u20133590.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR50","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1210\/jcem.83.4.4750","volume":"83","author":"R Coutant","year":"1998","unstructured":"Coutant R, Carel JC, Letrait M, Bouvattier C, Chatelain P, Coste Jet al. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children.J Clin Endocrinol Metab 1998; 83: 1070\u20131074.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF02760699_CR51","first-page":"245","volume":"158","author":"SE Myers","year":"1999","unstructured":"Myers SE, Carrel AL, Whitman BY, Allen DB. Sustained benefit after 2 years of growth hormone treatment on body composition, fat utilization, physical strength, agility and growth in Prader-Willi syndrome.Eur J Pediatr 1999; 158: 245\u2013249.","journal-title":"Eur J Pediatr"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02760699.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02760699\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02760699","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T23:02:03Z","timestamp":1684191723000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02760699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["BF02760699"],"URL":"https:\/\/doi.org\/10.1007\/bf02760699","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}